NCT04708483 - DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions

Cancer, LungPerfusion Computed Tomography Target LesionCancer LiverMetastatic Lung CancerMetastatic Liver Cancer

Interventions

DEVICE

Extra DCE-CT scan

DCE-CT of thoracic tumors as an early biomarker for treatment monitoring in comparison with morphologic criteria.

Trial Locations (1)

RECRUITING

University Hospital, Ghent, Ghent